NCT04386564View on ClinicalTrials.gov

Kidney Injury Severity and COVID-19

CompletedOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

September 1, 2020

Conditions
COVID-19Kidney Injury
Interventions
DIAGNOSTIC_TEST

mRNA in urine test

Assessment of renal function, expression of viral RNA in urine and assessment of radiological changes will be performed

Trial Locations (1)

119991

Sechenov University., Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT04386564 - Kidney Injury Severity and COVID-19 | Biotech Hunter | Biotech Hunter